Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $518.93 million. The enterprise value is $481.15 million.
| Market Cap | 518.93M |
| Enterprise Value | 481.15M |
Important Dates
The next confirmed earnings date is Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 55.09 million shares outstanding. The number of shares has increased by 4.73% in one year.
| Current Share Class | 55.09M |
| Shares Outstanding | 55.09M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 19.30% |
| Owned by Institutions (%) | 33.02% |
| Float | 35.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.22 |
| Forward PS | 5.42 |
| PB Ratio | 9.74 |
| P/TBV Ratio | 9.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.79.
| Current Ratio | 4.95 |
| Quick Ratio | 4.45 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.82 |
Financial Efficiency
Return on equity (ROE) is -48.42% and return on invested capital (ROIC) is -11.97%.
| Return on Equity (ROE) | -48.42% |
| Return on Assets (ROA) | -10.84% |
| Return on Invested Capital (ROIC) | -11.97% |
| Return on Capital Employed (ROCE) | -23.32% |
| Weighted Average Cost of Capital (WACC) | 17.11% |
| Revenue Per Employee | $448,263 |
| Profits Per Employee | -$159,984 |
| Employee Count | 186 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | -31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.17% in the last 52 weeks. The beta is 2.45, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.45 |
| 52-Week Price Change | +86.17% |
| 50-Day Moving Average | 8.63 |
| 200-Day Moving Average | 6.01 |
| Relative Strength Index (RSI) | 59.84 |
| Average Volume (20 Days) | 288,220 |
Short Selling Information
The latest short interest is 1.24 million, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.42M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $83.38 million and -$29.76 million in losses. Loss per share was -$0.56.
| Revenue | 83.38M |
| Gross Profit | 73.34M |
| Operating Income | -19.67M |
| Pretax Income | -29.79M |
| Net Income | -29.76M |
| EBITDA | -19.26M |
| EBIT | -19.67M |
| Loss Per Share | -$0.56 |
Balance Sheet
The company has $79.75 million in cash and $41.97 million in debt, with a net cash position of $37.78 million or $0.69 per share.
| Cash & Cash Equivalents | 79.75M |
| Total Debt | 41.97M |
| Net Cash | 37.78M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 52.89M |
| Book Value Per Share | 0.97 |
| Working Capital | 80.94M |
Cash Flow
In the last 12 months, operating cash flow was -$23.24 million and capital expenditures -$93,000, giving a free cash flow of -$23.33 million.
| Operating Cash Flow | -23.24M |
| Capital Expenditures | -93,000 |
| Depreciation & Amortization | 410,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.33M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 87.96%, with operating and profit margins of -23.60% and -35.69%.
| Gross Margin | 87.96% |
| Operating Margin | -23.60% |
| Pretax Margin | -35.73% |
| Profit Margin | -35.69% |
| EBITDA Margin | -23.10% |
| EBIT Margin | -23.60% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -5.91% |
| FCF Yield | -4.50% |
Analyst Forecast
The average price target for Sight Sciences is $10.17, which is 7.96% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.17 |
| Price Target Difference | 7.96% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 12.27% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.19 |
| Piotroski F-Score | 4 |